Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter randomized controlled study. [electronic resource]
Producer: 20200505Description: 1262 p. digitalISSN:- 1471-2407
- Adolescent
- Adult
- Aged
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Chemoradiotherapy
- Cisplatin -- therapeutic use
- Docetaxel -- therapeutic use
- Drug Tolerance
- Female
- Fluorouracil -- therapeutic use
- Humans
- Induction Chemotherapy
- Lymphatic Metastasis -- therapy
- Male
- Middle Aged
- Nasopharyngeal Carcinoma -- therapy
- Nasopharyngeal Neoplasms -- therapy
- Neoplasm Staging
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.